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Abstract Aims of the study were (1) to establish a method
for quantification of chlorhexidine (CHX) in small volumes
and (2) to determine CHX release from differently concen-
trated CHX-containing preparations, varnishes, and a CHX
gel applied on artificial fissures. CHX determination was
conducted in a microplate reader using polystyrene wells.
The reduced intensity of fluorescence of the microplates
was used for CHX quantification. For verification of the
technique, intra- and inter-assay coefficients of variation were
calculated for graded series of CHX concentrations, and
the lower limit of quantification (LLOQ) was determined.
Additionally, artificial fissures were prepared in 50 bovine
enamel samples, divided into five groups (A–E, n=10) and
stored in distilled water (7 days); A: CHX-varnish EC40;
B: CHX-varnish Cervitec; C: CHX-gel Chlorhexamed; D:
negative control, no CHX application; and E: CXH-diacetate
standard (E1, n=5) or CHX-digluconate (E2, n=5) in the
solution. The specimens were brushed daily, and CHX in
the solution was measured. The method showed intra- and
inter-assay coefficients of variation of <10 and <20%, respec-
tively; LLOQ was 0.91–1.22 nmol/well. The cumulative
CHX release (mean±SD) during the 7 days was: EC40
(217.2±41.8 nmol), CHX-gel (31.3±8.5 nmol), Cervitec
(18.6±1.7 nmol). Groups A–C revealed a significantly
higher CHX release than group D and a continuous CHX-
release with the highest increase from day 0 to 7 for EC40
and the lowest for Chlorhexamed. The new method is a
reliable tool to quantify CHX in small volumes. Both tested
varnishes demonstrate prolonged and higher CHX release
from artificial fissures than the CHX-gel tested.
Keywords Varnish . Chlorhexidine . EC40 . Cervitec .
Chlorhexamed gel . CHX determination
Introduction
Chlorhexidine (CHX) is considered as one of the most
popular agents to reduce the risk of developing new caries
lesions [21, 26, 32]. One reason for this estimation is the
broad antiseptic property of CHX against a wide variety of
gram-negative and gram-positive organisms. In high con-
centrations, CHX is bactericidal via destruction of the cell
membrane [16]. The antimicrobial activity of CHX is due
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to the positively charged parts of the CHX molecule, which
react with the phosphate groups of lipopolysaccharides in
the bacterial cell wall. At lower concentrations, CHX has
bacteriostatic properties. For use in the oral cavity, CHX is
available and effective in different delivery systems, such
as sprays, mouthwashes, CHX-containing glass ionomer
cement gels, chips, and varnishes [1, 4, 5, 12, 19, 25, 27, 33].
Varnishes are usually applied in the dental office and act as a
kind of slow-releasing device, thus resulting in a prolonged
intraoral CHX availability as compared to mouthwashes
and gels.
Chlorhexidine varnishes might be used for prevention of
fissure caries, although the results of studies in high-risk
caries patients are inconclusive [38, 39]. Especially in the
time period shortly after eruption of the teeth, it is often
difficult to apply adhesively attached fissure sealants due to
insufficient moisture control. In this phase, CHX varnishes
might help to fight bacterial inoculation of the fissure
systems and to postpone application of fissure sealants to a
time point when moisture control could be guaranteed.
However, application of CHX varnish onto fissures
resulted in contradictory results in terms of fissure caries
reduction in studies running over periods from 9 months to
3 years [39]. On the one hand, some recent split-mouth
controlled studies and randomized clinical trials of various
research groups [3, 7, 8, 10, 23] proved the CHX varnish
Cervitec (1% CHX and 1% thymol) being effective to sig-
nificantly reduce the caries incidence in molar fissures in
groups of children and adolescents. In contrast, in a ran-
domized controlled study using the 40% CHX varnish
EC40, no statistically significant benefit was recorded in
the group treated with the varnish as compared to the
placebo group [15].
CHX has the ability to adsorb onto tooth surfaces and
oral mucosa, with a slow release later on. When applied
onto fissures, it is additionally possible that remnants of
the applied varnish will retain even after mechanical
impact, such as mastication and toothbrushing. These
varnish remnants will allow for prolonged and elevated
CHX levels in the fissure systems. Previous studies using
Cervitec could show that this varnish is able to release
CHX for as long as 3 months with the majority of release
during the first 4 weeks of storage [20]. In this study, the
varnish was applied on microscope glass slides (2×7.5×
2.5 cm) resulting in a measurable amount of CHX release
from the varnish into the 50-ml sample solution. This
experimental setup allowed for determination of the CHX
release with a common ultraviolet (UV) spectrophotometer.
Using UV absorption for CHX determination needs both
expensive quartz cuvettes and a sample volume of at least
3 ml. Additionally, application of varnishes on glass plates
does not simulate intraoral conditions with mechanical
impact such as toothbrushing. When applied onto the fissure
system of a tooth, which is regularly brushed, only small
quantities of CHX are expected to be released into the
solution used to store the respective specimens. Thus, to
increase the concentration in the solution, the specimens
should be stored in small sample volumes. However, using
the above-mentioned UV-absorption method as done in var-
ious studies [20, 28, 31], it is difficult to measure reliably
such low concentrations in small sample volumes. More
sensitive methods, such as high-performance liquid chro-
matography or ion mobility spectrometry have also been
described for CHX determination [9, 11, 37, 40]. However,
these approaches do need extensive sample preparation
and expensive devices and does not allow remeasuring in
the same sample solution, which is needed for monitoring
the release over a certain period of time. Additionally,
colorimetric methods using different markers for CHX,
such as eosin, bromthymolblue, methylene orange and
bromchresol green, have been described for CHX deter-
mination [2, 13, 18, 30, 42]. Disadvantages of these
methods are either the low sensitivity or the fact that the
CHX has to be extracted in the sample solution using
chloroform, not allowing monitoring in the same sample
solution over a period of time.
It would be useful for clinical practice to have infor-
mation about the characteristics of CHX release from
varnishes applied onto tooth surfaces and fissure systems.
Thus, the aims of the study were:
1) To develop and to verify an unexpensive, sensitive
method for determination of low CHX concentrations
in small sample volumes
2) To determine the period of time of chlorhexidine
release from CHX varnishes applied on artificial
fissures subjected to toothbrushing
Materials and methods
Principle of the method to quantify CHX in small sample
volumes
The following principle for quantification of CHX in small
volumes was developed in the laboratory of the authors.
The determination of CHX was conducted using poly-
styrene flat-bottom microplate wells (Sarstedt, Nümbrecht,
Germany) in a microplate reader (SpectraMax M2, Molec-
ular Devices, Ismaning/Munich, Germany). When excited
with 280 nm from the top, the bottom of the polysterene
plate shows fluorescence, resulting in light emittance with a
wavelength of 360–380 nm. Chlorhexidine is able to absorb
light with the wavelength of 280 nm during the passage but
not the emitted light, resulting in a decreased intensity of
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the fluorescence of the polystyrene (measured as RFU,
relative fluorescence intensity; Fig. 1). When calculating
the relation between the RFU of a blank well and a well
containing a CHX solution excited at 280 nm, the best
results are achieved at emitted fluorescence of 370 nm. This
finding indicates the high sensitivity to determine CHX
when measuring intensity of emitted fluorescence at
370 nm (Fig. 1).
In a first step, the unfilled polystyrene wells of the
microplates were excited with 280 nm, and the emitted
fluorescence was recorded at 370 nm to determine the blank
value. Then, 370 μl each (1 cm height in a well) of a
standard dilution series with 0, 7, 14, 28, 56, 111, and
223 μmol/l CHX was applied into the wells to create a
standard calibration curve. The final content of CHX in the
respective wells corresponded to 0, 2.6, 5.2, 10.3, 20.6,
41.2, and 82.4 nmol CHX per well. The standard cali-
bration curve was fitted with polygonal interpolation.
Relative fluorescence was expressed as percentage of the
blank value and was recorded. By means of the standard
calibration curve, the absolute quantity of CHX (nmol) per
well is determined. Since the CHX regimes later used in the
study contained different CHX formulations, standard
calibration curves were recorded for both CHX-diacetate
and CHX-digluconate. No differences were observed for
these two compounds with respect to the calibration curves
recorded (Fig. 2). Owing to that finding, CHX-diacetate
was used in the study later on for measuring the CHX
release from the CHX-treated specimens.
Validation of the method
Precision, reproducibility and lower limit of quantification
(LLOQ) were checked according to the guidance for bio-
analytical method validation recently described by Shah
et al. [34, 35]. The measurements were performed at room
temperature of 25°C. The experiments were run with ten
repeats in series using graded dilution series of CHX-
diacatate from 0.7 to 78.4 nmol/well. Either 100, 200 or
370 μl were pipetted into each well.
Intra-assay coefficient of variation of CHX recovery
was calculated for assessing precision of the test since it
considers both distribution of the data and slope of the
calibration curve. Threshold for acceptable precision was
set at a coefficient of variation of <10%. For example, an
intra-assay coefficient of variation of 10% would mean that
a CHX concentration of 100 μmol/l in a respective solution
would yield a reading in a range of 90–110 μmol/l.
Reproducibility was checked by calculating the inter-
assay coefficient of variation. Therefore, for each solution,
Fig. 1 Above, schematic
drawing of the principle of the
CHX-determination (right)
measuring the reduced fluores-
cence of the polysterene plates
due to absorbance of the excita-
tion light by the CHX in the
solution (left). Below, intensity
(relative fluorescence units,
RFU) of emission wavelengths
(nm) determining a solution
without (no CHX) and with
0.01% CHX in the polysterene
plates excited with 280 nm.
Additionally, the relations
between the fluorescence inten-
sity measured for the solution
without and with 0.01% CHX
are presented
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ten calibration curves were constructed, and recovery of
CHX and inter-assay coefficient of variation was calculat-
ed. Threshold for acceptable reproducibility was set at an
inter-assay coefficient of variation of <20%. For example,
an inter-assay coefficient of variation of <20% would mean
that using different calibration curves a CHX concentration
of 100 μmol/l in a respective solution would yield a result
of 80–120 μmol/l.
Lower limits of quantification (nmol/well) for the respec-
tive solutions were calculated as CHX concentration at the
particular point on the calibration curve presenting the
following: (mean value of blank fluorescence) minus (5×
standard deviation). As a threshold, the lowest standard on
the calibration curve (2.6 nmol/well) should be higher than
the LLOQ [34, 35].
Preparation of enamel samples
Fifty bovine central lower incisors were used in the study.
After extraction, the teeth had been stored in 0.1% thymol
until use. Cylindrical samples (5 mm in diameter) were
prepared from the labial surface with a diamond-coated
trephine drill (Geb. Brasseler/Komet, Lemgo, Germany).
The cylinders were then embedded in acrylic resin
(Technovit 4071®, Kulzer, Wehrheim, Germany). Subse-
quently, the specimens were ground flat with water-cooled
carborundum discs (500–4,000 grit; Water Proof Silicon
Carbide Paper, Struers, Erkrath, Germany). Grinding and
polishing resulted in approximately 100 μm of the enamel
being removed. The amount of abraded enamel was con-
trolled with a micrometer (Digimatic; Mitutoyo-Meßgeräte,
Leonberg, Germany).
Using a diamond-coated disc (Komet), grooves (0.5 mm
in depth and 0.2 mm in width) were prepared on the
polished surface under constant water-cooling. The grooves
were arranged in the form of four crosses. A special device
designed for this purpose was utilized to guarantee
standardized preparation of the grooves. After cleaning
the artificial fissures with water and air-drying, the samples
were divided into five groups (A–E) of ten samples each:
– Group A (CHX varnish EC40)
The varnish EC40 (explore, NL-6501, Nijmegen, Nether-
lands) contains 40% CHX-diacetate in a sandarac resin base,
dissolved in water-free alcohol and is packed in glass
carpules. The varnish was applied onto the enamel surface
of the samples in a thin layer of about 1 mm using a syringe
with a blunt needle.
After setting of the varnish for 10 min, gross material
excess was removed with a probe as instructed by the man-
ufacturer. Subsequently, the surfaces of the enamel samples
were brushed with 40 strokes in an automatic brushing
machine [41]. The toothbrush Oral-B classic soft (Procter &
Gamble, Schwalbach am Taunus, Germany) with a load of
200 g was used in a toothpaste slurry consisting of the
dentifrice elmex (Gaba, Münchenstein, Switzerland) dis-
solved in distilled water in a ratio of 1 g:3 ml. The samples
were then stored in 700 μl distilled water in closed poly-
ethylene containers for 7 days and brushed every day.
– Group B (CHX varnish Cervitec)
Cervitec (Ivoclar Vivadent, Schaan, Liechtenstein) con-
tains 1% CHX-diacetate and 1% thymol dissolved in ethanol,
ethyl acetate and a polymer (polyvinyl butyral), and is packed
in glass vials (1.5 ml). The user’s instruction recommends
the first toothbrushing not until 24 h after application of the
varnish. The varnish was applied in two layers onto the
enamel samples with a microbrush.
The samples were also transferred to a vial containing
700 μl of distilled water. The first brushing was conducted
after a period of 24 h storage. Thereafter, the samples were
brushed every day as described for group A.
– Group C (CHX gel Chlorhexamed)
The Chlorhexamed gel (GlaxoSmithKline, Bühl, Germany)
contains 1% CHX-digluconate 1%. The gel was applied with a
microbrush onto the enamel surfaces in a layer of about 1 mm
thickness. First brushing of the samples was conducted after
the application of the gel, before transferral to the storage
media. Thereafter, the samples were brushed every day as
described for group A.
– Group D (negative controls)
Neither gel nor varnish was applied on the enamel
samples. These samples were brushed and were stored in
700 μl distilled water also.
– Group E
No application of CHX onto the enamel surface was
done, like in group D. However, these samples were not
brushed and were subdivided into two subgroups (E1 and
E2) of five specimens each with respect to the storage
media. In group E1, samples were stored in 700 μl of a
solution containing 55.4 μmol/l chlorhexidine-diacetate
(i.e., 38.8 nmol CHX-diacetate). In group E2, the storage
media contained 55.7 μmol/l chlorhexidine-digluconate
in the 700 μl solution (i.e., 39.0 nmol CHX-digluconate).
Groups E1 and E2 were included in the study for checking
adsorption of the different CHX compounds to the enamel
Fig. 2 Mean intensity (relative fluorescence units, RFU) of differently
concentrated solutions of CHX-digluconate and CHX-diacatate
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surface. The values recorded for these samples were later
used to calculate the net release from the different CHX
preparations.
Determination of CHX in the storage media
As mentioned above, each sample was stored in 700 μl
distilled water for a period of 7 days. On each day, 370 μl
were pipetted from the solution 3 h after brushing and used
for determination of CHX in the microplate reader as
described above. After determination, the 370 μl liquid
sample was retransferred to the vials containing the enamel
samples. Thus, at the end of the experiment, CHX mea-
surement in the solution represented the cumulative CHX
release over the 7-day period. The values recorded for each
day were corrected by the value obtained in group E
(adsorption to enamel surface), so that the net release of the
CHX regimes was used in the statistical analysis and
presentation of the data in the result section.
The determination gave the absolute amount of CHX
(nmol) in the 370 μl samples. With this value, the absolute
amount of CHX (nmol)] released from the CHX-treated
enamel samples into the 700 μl storage solution was
calculated.
Statistical analysis
Comparisons between the different groups regarding CHX
release directly after application of the regimes were per-
formed with one-way analysis of variance (ANOVA). The
increase of CHX release over time (starting after day 0 to day
7) was conducted with a weighted one-way ANOVA and
post hoc-tests with adjustments according to Bonferroni–
Dunn. The level of significance was set at P<0.05.
Results
Validation of the method for CHX-determination
The recovery rate of CHX measured in different volumes
(100, 200, and 370 μl) with 0.7–78.4 nmol CHX per
well ranged from 99.1 to 100.4%. In Figs. 3 and 4, the
intra- and inter-assay coefficients of variation of the CHX
determination with different concentrations and different
volumes are given. The intra-assay coefficients of varia-
tion amounted to <10% for most of the solutions tested
except for levels below 2.8 nmol/well in 100 or 200 μl
and below 3.5 nmol/well in 370 μl solution. All inter-
assay coefficients of variation were below the threshold
level of 20%. Lower limits of quantification for the dif-
ferent volumes applied to the wells of the microtiter plate
were calculated as follows: 1.22 nmol/well (100 μl),
0.91 nmol/well (200 μl) and 1.01 nmol/well (370 μl).
Thus, the requirement was fulfilled that the LLOQ should
be lower than the lowest standard on the calibration curve
(2.6 nmol/well).
CHX-determinations in test and control samples
The control group did not show any measurable amounts
of CHX in the solutions at any time during the experiment.
The samples of group E showed a loss of both CHX-
diacatate (E1) and CHX-digluconate (E2) from the solu-
tions during the 7-day period. From the 38.8 nmol of
CHX-diacetate and 39.0 nmol CHX-digluconate in the
solutions, only 22.9±4.9 nmol (E1) and 22.4±8.5 nmol
(E2) could be recovered on day 7. This finding indicated
that about 41–42% of the CHX from these solutions were
adsorbed on the enamel surfaces during the 7-day period.
Fig. 3 Intra-assay coefficients of variation (CV%) for different CHX
amounts (nmol/well) measured in volumes of 100, 200, and 370 μl in
the wells of microtiter plates. The 10% threshold area is marked with a
dotted line
Fig. 4 Inter-assay coefficients of variation (CV%) for different CHX
amounts (nmol/well) determined in volumes of 100, 200, and 370 μl
in the wells of microtiter plates. The 20% threshold area is marked
with a dotted line
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In Fig. 5, the cumulative CHX net release from the
different regimes are given. Due to the different CHX con-
centrations of the regimes, significantly different amounts
of CHX were released especially directly after application.
The release directly after application at day 0 was therefore
statistically significantly highest for EC40 as compared to
the two other treatments (P<0.0001). The varnish Cervitec
released the significantly lowest amount of CHX (P<
0.0001). For better comparison of the CHX release over
time, the cumulative CHX release after day 0 to 7 was addi-
tionally calculated. This means that the values of day 1 to 7
were added. All test groups showed a continuous release
of CHX after day 0 to 7 with the statistically highest
increase for EC40 and the lowest for Chlorhexamed. The
increases from day 0 to 7 and the P values of the increases
were as follows: EC40 (174.3±26 nmol; P<0.0001),
Cervitec (17.9±1.6 nmol; P<0.0001) and Chlorhexamed
(7.4±5.1 nmol; P=0.0025).
Discussion
The new method for CHX determination fulfilled all require-
ments for bioanalytical measurements as described by [35,
34]. All parameters checked, such as intra- and inter-assay
coefficients of variance as well as the recovery rate and
the lower limit of quantification, proved the method being
suitable for detection of low CHX-concentrations in small
sample volumes. The LLOQ calculated was in a range of
about 1.0 nmol/well. Thus, the LLOQ fell below the CHX
release per day measured in a pilot study for samples treated
with the CHX gel Chlorhexamed. To increase the amount
of CHX in the storage solutions, we, therefore, had decided
to measure the CHX release in the same solution during the
7-day experimental period. This means that the CHX-
treated samples were not transferred to a fresh solution for
measuring daily release, as done in studies determining
release of other substances from dental materials, such as
fluoride release from glass ionomer cements [6, 14, 24, 29].
The same procedure of measuring CHX in the identical
solution during storage was done by Huizinga et al. [20],
when determining CHX release from Cervitec during
16 weeks. Due to this necessity, no daily release of CHX
could be determined, and a cumulative release over time
was determined. This renders it nearly impossible to esti-
mate the CHX release from the enamel samples with
respect to antimicrobial potential in the in vivo situation.
Additionally, for the situation in the oral cavity, it has to
be considered that CHX, which is released from a carrier,
is diluted or bound to various surfaces and might interact
with salivary proteins and salivary bacteria. Nevertheless,
in the present study, the cumulative release for all forms of
CHX application was above the minimal inhibitory
concentration (MIC) of CHX, which is given as 0.19–
2.0 μg/ml [17]. Taking the molar weight of 506 for CHX,
the MIC would equal 0.26–2.76 nmols in our storage solu-
tion volume of 0.7 ml. This value was exceeded by both the
varnishes and the gel at least directly after application.
Even the approximate daily release from the two varnishes
was above this calculated MIC. Nevertheless, extrapolation
of the obtained in vitro data to the clinical situation with
respect to possible bacterial inhibition should be done with
caution.
The results of the study showed clearly that the two CHX
varnishes tested have the potential to release measurable
amounts of CHX after application to an artificial fissure
system which is brushed regularly. Furthermore, after
application of the Chlorhexamed gel, a constant although
lower release as compared to the varnishes was recorded.
The higher CHX release from the varnish EC40 as compared
to Cervitec might be attributed to the higher concentration of
the EC40. This becomes obvious when referring to the CHX
release immediately after application. However, also in the
period after day 1, the daily release was higher from EC40
represented by the steeper slope of the regression line of
EC40 as compared to Cervitec (Fig. 5). Nevertheless, in
contrast to the CHX gel, also Cervitec showed retention in
the fissure system under the simulated toothbrushing
procedure resulting in a prolonged and steady CHX release
after application of the varnish onto the fissures. The better
retention of EC40 in contrast to Cervitec might be
attributed to the higher stickiness of EC40 and the fact that
EC40 hardens to a solid consistency difficult to remove
from the fissures by toothbrushing.
Fig. 5 Cumulative mean (and SD) of net CHX (nmol) recorded in the
storage solutions containing the enamel samples either treated with
Cervitec, EC40, or Chlorhexamed. The CHX determined in the storage
solution is given for each day of the 7-day-period of storage in the same
solution. A regression line is drawn for each CHX application
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The study is the first study measuring CHX release after
application onto a fissure system. The extensions of the
fissures were prepared as previously done by Smits and
Arends [36] in an in vitro study. Use of artificial fissures
was necessary in our study to standardize the determination
of CHX release. However, it should be noted that natural
fissures might have various shapes, thus allowing different
retention of a varnish applied and different access of
toothbrush bristles. This means that retention of the tested
CHX regimes to natural fissures might, in some part, be
different as compared to the present in vitro situation.
The present study was limited to a period of 7 days.
For a better understanding of the CHX action in the oral
cavity, a longer observation period would be desirable. In
a future study, it should be clarified how long the two
varnishes tested are able to show a measurable release of
CHX. However, antimicrobial therapies utilizing CHX
for reducing caries risk are mostly limited to a certain
period, ranging from a single application of a highly con-
centrated product to multiple applications of lower con-
centrated gels during this treatment period [7, 10, 15, 22,
43]. These restricted periods seem to be sufficient to
reduce the critical mass of carious-inducing bacteria for a
certain period of time, as shown in numerous previous
studies. Thus, it could be assumed that the CHX release
as observed in the present study for 7 days could con-
tribute to reducing the carious risk in fissures. Neverthe-
less, repeated applications after a certain period of time
of at least 6 months seem to be advisable [26].
In conclusion, the study proved the newly introduced
method as a reliable tool to detect and quantify minimal
CHX contents in small volumes. Additionally, under the
chosen conditions, both tested varnishes demonstrated
prolonged and higher CHX release from artificial fissures
in comparison to the CHX gel tested.
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